title: Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer.
abstract: Chemotherapy resistance is a major obstacle in cancer treatment, yet the mechanisms of response to specific therapies have been largely unexplored in vivo. Employing genetic, genomic, and imaging approaches, we examined the dynamics of response to a mainstay chemotherapeutic, cisplatin, in multiple mouse models of human non-small-cell lung cancer (NSCLC). We show that lung tumors initially respond to cisplatin by sensing DNA damage, undergoing cell cycle arrest, and inducing apoptosis-leading to a significant reduction in tumor burden. Importantly, we demonstrate that this response does not depend on the tumor suppressor p53 or its transcriptional target, p21. Prolonged cisplatin treatment promotes the emergence of resistant tumors with enhanced repair capacity that are cross-resistant to platinum analogs, exhibit advanced histopathology, and possess an increased frequency of genomic alterations. Cisplatin-resistant tumors express elevated levels of multiple DNA damage repair and cell cycle arrest-related genes, including p53-inducible protein with a death domain (Pidd). We demonstrate a novel role for PIDD as a regulator of chemotherapy response in human lung tumor cells.
authors.affiliation: David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, 02139, USA.
authors.forename: Trudy G
authors.initials: TG
authors.lastname: Oliver
authors.forename: Kim L
authors.initials: KL
authors.lastname: Mercer
authors.forename: Leanne C
authors.initials: LC
authors.lastname: Sayles
authors.forename: James R
authors.initials: JR
authors.lastname: Burke
authors.forename: Diana
authors.initials: D
authors.lastname: Mendus
authors.forename: Katherine S
authors.initials: KS
authors.lastname: Lovejoy
authors.forename: Mei-Hsin
authors.initials: MH
authors.lastname: Cheng
authors.forename: Aravind
authors.initials: A
authors.lastname: Subramanian
authors.forename: David
authors.initials: D
authors.lastname: Mu
authors.forename: Scott
authors.initials: S
authors.lastname: Powers
authors.forename: Denise
authors.initials: D
authors.lastname: Crowley
authors.forename: Roderick T
authors.initials: RT
authors.lastname: Bronson
authors.forename: Charles A
authors.initials: CA
authors.lastname: Whittaker
authors.forename: Arjun
authors.initials: A
authors.lastname: Bhutkar
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Lippard
authors.forename: Todd
authors.initials: T
authors.lastname: Golub
authors.forename: Juergen
authors.initials: J
authors.lastname: Thomale
authors.forename: Tyler
authors.initials: T
authors.lastname: Jacks
authors.forename: E Alejandro
authors.initials: EA
authors.lastname: Sweet-Cordero
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D002352:Carrier Proteins / Q000378:metabolism; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000494:pharmacology* / Q000627:therapeutic use*; D004260:DNA Repair / Q000187:drug effects*; D053418:Death Domain Receptor Signaling Adaptor Proteins; D004195:Disease Models, Animal; D019008:Drug Resistance, Neoplasm / Q000502:physiology; D020869:Gene Expression Profiling; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D020411:Oligonucleotide Array Sequence Analysis
chemical_list: D000970:Antineoplastic Agents; D002352:Carrier Proteins; D053418:Death Domain Receptor Signaling Adaptor Proteins; C414729:Pidd1 protein, mouse; D002945:Cisplatin
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14298-302
references.pmid: 12370430
references.citation: Mol Pharmacol. 2000 Mar;57(3):503-11
references.pmid: 10692490
references.citation: Nature. 2001 Apr 26;410(6832):1111-6
references.pmid: 11323676
references.citation: Biochemistry. 1995 Jul 4;34(26):8474-80
references.pmid: 7599137
references.citation: Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4210s-4214s
references.pmid: 15217960
references.citation: Nature. 1995 Oct 12;377(6549):552-7
references.pmid: 7566157
references.citation: J Neurosci. 2007 Aug 29;27(35):9451-7
references.pmid: 17728458
references.citation: Cell. 2005 Dec 16;123(6):1079-92
references.pmid: 16360037
references.citation: Cancer Res. 2005 Nov 15;65(22):10280-8
references.pmid: 16288016
references.citation: J Biol Chem. 2004 May 28;279(22):23477-85
references.pmid: 15026414
references.citation: Cancer Res. 2002 Sep 1;62(17):4899-902
references.pmid: 12208738
references.citation: Cancer Res. 2000 Jun 15;60(12):3155-9
references.pmid: 10866304
references.citation: Nat Genet. 2000 Sep;26(1):122-7
references.pmid: 10973264
references.citation: Mol Cell Biol. 2006 Dec;26(24):9377-86
references.pmid: 17000754
references.citation: Mol Pharmacol. 2006 Oct;70(4):1390-4
references.pmid: 16847145
references.citation: Cell Cycle. 2009 Oct 15;8(20):3355-64
references.pmid: 19770592
references.citation: Cancer Res. 1996 Feb 1;56(3):556-62
references.pmid: 8564971
references.citation: Nat Genet. 2001 Dec;29(4):418-25
references.pmid: 11694875
references.citation: Science. 2009 Jun 12;324(5933):1457-61
references.pmid: 19460966
references.citation: Int J Cancer. 2004 Jun 20;110(3):352-61
references.pmid: 15095299
references.citation: Nucleic Acids Res. 2006 Mar 29;34(6):e47
references.pmid: 16571898
references.citation: Nature. 1995 Aug 31;376(6543):785-8
references.pmid: 7651539
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12117-22
references.pmid: 17626183
references.citation: EMBO J. 2007 Jan 10;26(1):197-208
references.pmid: 17159900
references.citation: Mol Cell. 2003 Apr;11(4):1109-17
references.pmid: 12718895
references.citation: Anticancer Res. 1998 Mar-Apr;18(2A):1085-9
references.pmid: 9615770
references.citation: J Clin Invest. 1994 Aug;94(2):703-8
references.pmid: 8040325
references.citation: N Engl J Med. 2006 Sep 7;355(10):983-91
references.pmid: 16957145
references.citation: Science. 1982 Dec 10;218(4577):1075-82
references.pmid: 6890712
references.citation: Cell. 2009 Feb 6;136(3):508-20
references.pmid: 19203584
references.citation: Nature. 1999 Jun 24;399(6738):806-9
references.pmid: 10391249
references.citation: Nat Rev Cancer. 2008 Mar;8(3):193-204
references.pmid: 18256616
references.citation: Cancer Res. 2003 Mar 15;63(6):1311-6
references.pmid: 12649192
references.citation: J Clin Invest. 2007 May;117(5):1370-80
references.pmid: 17446929
references.citation: Nat Genet. 2005 Jan;37(1):48-55
references.pmid: 15608639
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
references.pmid: 16199517
references.citation: Clin Cancer Res. 2000 Mar;6(3):1031-7
references.pmid: 10741731
references.citation: Mol Cell. 2004 Nov 19;16(4):521-35
references.pmid: 15546613
references.citation: J Biol Chem. 2008 Mar 7;283(10):6572-83
references.pmid: 18162465
references.citation: Mol Pharmacol. 2009 Jul;76(1):208-14
references.pmid: 19403702
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16663-8
references.pmid: 17925434
references.citation: Nat Rev Cancer. 2007 Aug;7(8):573-84
references.pmid: 17625587
references.citation: Nature. 2008 Feb 28;451(7182):1111-5
references.pmid: 18264088
references.citation: Nat Rev Drug Discov. 2005 Apr;4(4):307-20
references.pmid: 15789122
references.citation: Carcinogenesis. 1988 Jul;9(7):1283-7
references.pmid: 2898306
references.citation: Nat Med. 2000 Sep;6(9):1029-35
references.pmid: 10973324
references.citation: Nature. 1969 Apr 26;222(5191):385-6
references.pmid: 5782119
references.citation: Nature. 2008 Feb 28;451(7182):1116-20
references.pmid: 18264087
references.citation: Genes Dev. 2001 Dec 15;15(24):3243-8
references.pmid: 11751630
references.citation: Genes Chromosomes Cancer. 2006 Apr;45(4):338-48
references.pmid: 16323170
references.citation: Science. 2004 May 7;304(5672):843-6
references.pmid: 15073321
references.citation: Science. 1990 Mar 23;247(4949 Pt 1):1457-61
references.pmid: 2108497
references.citation: Cell. 2002 May 3;109(3):335-46
references.pmid: 12015983
references.citation: Clin Cancer Res. 2008 Mar 1;14(5):1291-5
references.pmid: 18316546
references.citation: Annu Rev Pharmacol Toxicol. 2008;48:495-535
references.pmid: 17937596
references.citation: Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11234-9
references.pmid: 16844783
references.citation: J Clin Oncol. 2007 Nov 20;25(33):5240-7
references.pmid: 18024870
references.citation: Lung Cancer. 2009 Dec;66(3):298-304
references.pmid: 19324449